A document, unique to regulatory submission for the United States, which evaluates the overall summaries and statistical analyses of the combined efficacy data from the various clinical studies conducted during drug testing. It is submitted to the Food and Drug Administration (FDA) in a New Drug Application (NDA), and included in section 5.3.5.3 of the CTD.